Інструкція із застосування ROFIXDOL GOLA
Зміст інструкції
RofixDol Gola 8.75 mg lemon and honey flavored lozenges
Flurbiprofen
Read this leaflet carefully before taking this medicine as it contains important information for you.
Always take this medicine exactly as described in this leaflet, or as your doctor or pharmacist has told you.
- Keep this leaflet. You may need to read it again.
- If you want more information or advice, ask your pharmacist.
- If any side effects occur, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
- See a doctor if you do not feel better or if your symptoms worsen after a short period of treatment.
Contents of this leaflet:
- 1. What RofixDol Gola is and what it is used for
- 2. What you need to know before you take RofixDol Gola
- 3. How to take RofixDol Gola
- 4. Possible side effects
- 5. How to store RofixDol Gola
- 6. Contents of the pack and other information
1. What is RofixDol Gola and what is it used for
RofixDol Gola contains the active ingredient flurbiprofen, belonging to the class of medicines
called “non-steroidal anti-inflammatory drugs (NSAIDs)”. These medicines are used to
relieve pain and inflammation.
RofixDol Gola is used to relieve symptoms such as irritation and/or inflammation of the mouth and
pharynx (for example gingivitis, stomatitis, pharyngitis).
Consult your doctor if you do not feel better or if you feel worse after short periods of treatment.
2. What you need to know before taking RofixDol Gola
Do not take RofixDol Gola
- if you are allergic to flurbiprofen, to other non-steroidal anti-inflammatory drugs (NSAIDs), to aspirin (acetylsalicylic acid) or to any of the other ingredients of this medicine (listed in section 6);
- if you have previously had allergic reactions such as asthma and/or skin rashes, wheezing after taking this medicine or other medicines belonging to the category of non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin (acetylsalicylic acid);
- if you have suffered from bleeding due to lesions of the stomach or intestine (gastrointestinal bleeding) or perforations due to treatments with medicines belonging to the category of non-steroidal anti-inflammatory drugs (NSAIDs);
- if you have or have had inflammation of the intestine characterized by lesions (ulcerative colitis);
- if you suffer from Crohn's disease, a chronic inflammatory bowel disease;
- if you have or have had two or more episodes of lesions or bleeding in the stomach or intestine (recurrent peptic ulcer or gastrointestinal bleeding);
- if you suffer from severe heart problems (severe heart failure);
- if you are in the last three months of pregnancy (see “Pregnancy and breastfeeding”).
Do not give this medicine to children under 12 years of age (see “Children”).
Warnings and precautions
Consult your doctor or pharmacist before taking RofixDol Gola if:
- you suffer from kidney, heart or liver problems;
- you have had asthma problems (bronchial asthma);
- you have suffered from lesions of the stomach or intestine (peptic ulcer) or other diseases of the stomach and intestines;
- you are already taking other non-steroidal anti-inflammatory drugs (NSAIDs) (see “Other medicines and RofixDol Gola”);
- you are elderly (because you are more likely to experience unwanted effects, in particular bleeding and perforation of the digestive tract, which can be life-threatening).
- you have an infection - refer to the “Infections” paragraph below.
During the use of RofixDol Gola:
- report to your doctor any unusual symptoms at the abdominal level (bleeding);
- stop treatment and consult your doctor who can define a suitable therapy if you notice the appearance of phenomena of local irritation.
Do not use this medicine for long periods. After short periods of treatment without
appreciable results, consult your doctor.
Infections
Non-steroidal anti-inflammatory drugs (NSAIDs) can mask signs of infections such as fever
and pain. This can delay appropriate treatment of the infection, which in turn can
lead to an increased risk of complications. If you take this medicine during
an infection and the symptoms of the infection persist or worsen, contact your
doctor or pharmacist immediately.
Side effects can be minimized by using the lowest effective dose for the shortest possible duration of treatment needed to control the symptoms (see “How to take
RofixDol Gola”).
Children
This medicine should not be given to children under 12 years of age (see
“Do not take RofixDol Gola”).
Other medicines and RofixDol Gola
Tell your doctor or pharmacist if you are taking, have recently taken or might take
any other medicine.
In particular, if you are already taking:
- aspirin (acetylsalicylic acid) as they may increase the unwanted effects,
- antiplatelet agents (used for the prevention and treatment of blood clots),
- selective serotonin reuptake inhibitors (SSRIs) (used for depression),
- corticosteroids (used to reduce inflammation),
- other NSAIDs including selective cyclooxygenase-2 inhibitors (used for pain and inflammation).
The side effects of RofixDol Gola, especially those affecting the gastrointestinal tract,
may be increased if taken at the same time as certain medicines.
Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are breastfeeding with
breast milk, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Oral formulations (e.g. tablets) of flurbiprofen can cause adverse effects in the unborn child.
It is not known whether the same risk applies to RofixDol Gola.
Do not take RofixDol Gola in the last three months of pregnancy.
Do not take RofixDol Gola in the first 6 months of pregnancy unless absolutely necessary and on
doctor's advice. If treatment is necessary during this period, you should take the
minimum dose for the shortest possible time.
The use of the medicine during pregnancy may delay the onset of labor and increase
its duration.
Breastfeeding
The administration of flurbiprofen is not recommended during breastfeeding. If you are breastfeeding
with breast milk, ask your doctor or pharmacist for advice before using this medicine.
Driving and operating machinery
The use of this medicine does not alter or negligibly alters the ability to drive vehicles or
operate machinery.
RofixDol Gola contains glucose and sucrose
This medicine contains glucose and sucrose, two types of sugars.
If your doctor has diagnosed you with an intolerance to certain sugars, contact him before taking
this medicine.
3. How to take RofixDol Gola
Take this medicine following exactly the instructions in this leaflet or as directed by your doctor or pharmacist. If you have any doubts, ask your doctor or pharmacist.
The recommended dose is:1 lozenge every 3-6 hours, as needed. Do not exceed 8 lozenges in 24 hours.
Dissolve the lozenge slowly in your mouth.
Use in children:Do not administer to children under 12 years of age.
Use in the elderly:No dose adjustments are necessary.
Caution: do not exceed the indicated doses without medical advice. Use only for short periods of
treatment.
The minimum effective dose should be used for the shortest time necessary to relieve
symptoms. If you have an infection, consult your doctor or pharmacist immediately if symptoms (such as
fever and pain) persist or worsen (see section 2).
Consult your doctor or pharmacist if you do not notice any improvement or if your condition worsens or
you develop new symptoms.
If you take more RofixDol Gola than you should
Considering the low content of active substance and its local use, it is unlikely that
overdose situations may occur. Symptoms of overdose may
include nausea, vomiting, and stomach and intestinal disorders (gastrointestinal irritation).
In case of accidental ingestion/intake of an excessive dose of the medicine, immediately notify
your doctor or go to the nearest hospital.
If you have any doubts about using this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported, particularly after administration of systemic
formulations (oral, parenteral):
- decreased platelets in the blood (thrombocytopenia);
- decreased production of blood cells (aplastic anemia);
- decreased white blood cells (agranulocytosis);
- severe allergic reaction (anaphylaxis) that can cause difficulty breathing or shock, swelling of the skin especially around the mouth and eyes (angioedema) and allergic reaction;
- dizziness and vertigo, confusion, severe headache (migraine) and hallucination;
- cardiovascular disorders, such as stroke (cerebrovascular accidents);
- visual disturbances and inflammation of the optic nerve (optic neuritis);
- tingling or altered sensitivity of the limbs or other parts of the body (paresthesia);
- depression;
- discomfort, feeling of fatigue and drowsiness;
- hearing disorders, such as perception of sounds in the ear (tinnitus);
- difficulty breathing (asthma, bronchospasm, dyspnea);
- nausea, vomiting, diarrhea;
- increased intestinal gas (flatulence);
- constipation;
- digestive difficulties (dyspepsia) and abdominal pain;
- presence of blood in the stool or dark stools (melena);
- presence of blood clots in vomit (hematemesis);
- inflammation of the oral cavity with the presence of lesions (ulcerative stomatitis);
- gastrointestinal bleeding and worsening of colitis (inflammation of the colon) and Crohn's disease (chronic inflammatory bowel disease);
- inflammation of the stomach (gastritis);
- stomach disorders characterized by lesions (peptic ulcer), perforation and bleeding from ulcer;
- skin irritation, such as rash, itching, hives;
- skin disorder that manifests through bleeding lesions (purpura);
- skin inflammations that manifest with the appearance of blisters (bullous dermatoses), which include Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme;
- kidney toxicity, including inflammation of the kidneys (interstitial nephritis);
- retention of proteins in the blood, fluid accumulation (edema) and increased cholesterol (hypercholesterolemia), a condition called nephrotic syndrome.
The use of this medicine, especially if prolonged, can give rise to phenomena of
sensitization or local irritation including a sensation of heat or tingling in the oropharynx.
Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your doctor or pharmacist. You can also
report side effects directly through the national reporting system at https://www.aifa.gov.it/content/segnalazioni-
reazioni-avverse. By reporting side effects you can help provide more information
about the safety of this medicine.
5. How to store RofixDol Gola
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the pack after “Scad”. The
expiry date refers to the last day of that month.
Do not dispose of any medicine in waste water or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What RofixDol Gola contains
- The active ingredient is: flurbiprofen. One lozenge contains 8.75 mg of flurbiprofen.
- The other ingredients are: sucrose, glucose, macrogol, potassium hydroxide, lemon flavour, levomenthol, honey.
Description of the appearance of RofixDol Gola and contents of the pack
RofixDol Gola is presented in the form of lozenges contained in blisters.
The pack contains 16 or 24 lozenges.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Pool Pharma S.r.l. – Via Basilicata, 9 – 20098 San Giuliano Milanese (MI)
Manufacturer
DOPPEL Farmaceutici S.r.l. - Via Volturno, 48 - 20089 Quinto de’ Stampi – Rozzano (MI)
LOZY'S PHARMACEUTICALS, S.L. Campus empresarial, 1, 31795 Lekaroz (Navarra) – SPAIN

- Країна реєстрації
- Лікарська формаLozenge, 8.75 MG
- Код АТХA01AD11
- Діюча речовина
- Потрібен рецептНі
- Виробник
- Ця інформація надана лише для ознайомлення і не є медичною порадою. Рішення щодо лікування завжди приймає лікар.
- Альтернативи до ROFIXDOL GOLAЛікарська форма: Mouthwash, 0.25 %Діюча речовина: variousВиробник: BAYER S.P.A.Рецепт не потрібенЛікарська форма: Lozenge, 8.75 mgДіюча речовина: variousВиробник: BAYER S.P.A.Рецепт не потрібенЛікарська форма: Mouthwash, 2,5 MG/MLДіюча речовина: variousРецепт не потрібен
Аналоги ROFIXDOL GOLA в інших країнах
Препарати з тією самою діючою речовиною, доступні в інших країнах.
Аналог ROFIXDOL GOLA у Польща
Аналог ROFIXDOL GOLA у Україна
Аналог ROFIXDOL GOLA у Іспанія
Лікарі онлайн щодо ROFIXDOL GOLA
Застосування, безпека та можливість призначення рецепта — за результатами медичної оцінки.
Отримайте рецепт на ROFIXDOL GOLA онлайн
Заповніть форму за 2 хвилини
Розкажіть про симптоми, історію хвороби та потрібний препарат.
Оберіть лікаря або ми призначимо
Оберіть спеціаліста або ми підберемо найближчого доступного лікаря.
Лікар розглядає ваш випадок
Зазвичай протягом 30 хвилин. Може ставити уточнювальні запитання в чаті.
Отримайте в будь-якій аптеці
Електронний рецепт надсилається на вашу пошту — дійсний по всій Польщі.
Часті запитання
ROFIXDOL GOLA не потребує рецепта в Італія. Ви можете обговорити з лікарем онлайн, чи підходить цей лікарський засіб для вашої ситуації.
Діюча речовина у ROFIXDOL GOLA — various. Це допомагає визначити препарати з тим самим складом, але під іншими торговими назвами.
ROFIXDOL GOLA виробляється компанією POOL PHARMA SRL. Назва бренду та упаковка можуть відрізнятися залежно від дистрибʼютора.
Лікарі, зокрема Сімейні лікарі, Психіатри, Дерматологи, Кардіологи, Ендокринологи, Гастроентерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Інфекціоністи, Алергологи, Геріатри, Педіатри, Онкологи, можуть оцінити доцільність застосування ROFIXDOL GOLA з урахуванням вашого стану та місцевих правил. Ви можете записатися на онлайн-консультацію, щоб обговорити симптоми та можливі подальші кроки.
Польща має добре розвинену систему охорони здоров'я у великих містах, таких як Варшава, Краків, Вроцлав і Гданськ. Аптеки широко доступні та працюють відповідно до чинного законодавства, забезпечуючи доступ до рецептурних препаратів.
Ви можете придбати ROFIXDOL GOLA у Варшаві, Кракові, Вроцлаві або Гданську в будь-якій аптеці за наявності дійсного рецепта.
Щоб отримати рецепт, ви можете скористатися Oladoctor:
Інші препарати з тією самою діючою речовиною (various) включають ASPI GOLA, ASPIGOLADOL, BENAKTIV GOLA. Вони можуть відрізнятися торговою назвою або формою випуску, але містять той самий терапевтичний компонент. Перед зміною або початком прийому нового препарату варто проконсультуватися з лікарем.
















